Konrad Glund

No open positions remaining

73 year

Health Technology

Commercial Services

Consumer Services

Profile

Konrad Glund is the founder of Vivoryon Therapeutics NV, which was founded in 1997.
He held the title of Chief Executive Officer from 2006 to 2018.
Dr. Glund is also the founder of IFB Halle GmbH.
He previously worked as Vice President-Corporate Development at Prosidion Ltd. and as a Principal at Martin-Luther-Universität Halle-Wittenberg.
Dr. Glund earned a doctorate degree from Martin-Luther-Universität Halle-Wittenberg.

Former positions of Konrad Glund

Companies	Position	End
VIVORYON THERAPEUTICS N.V.	Chief Executive Officer	30/04/2018
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Corporate Officer/Principal	-
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
IFB Halle GmbH	Chief Executive Officer	-

See the detail of Konrad Glund's experience

Training of Konrad Glund

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Konrad Glund's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Prosidion Ltd. Prosidion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures products for treatment of metabolic diseases	Health Technology
Vivoryon Therapeutics NV Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease	Commercial Services
Martin-Luther-Universität Halle-Wittenberg Martin-Luther-Universität Halle-Wittenberg Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IFB Halle GmbH